Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreciPed
NCT05330338Active, not recruiting
- Sponsor
- CHU de Nantes
- Start
- Sep 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Nantes. Primary endpoint: Identification of new genes/variants involved in congenital heart disease at 24 months. Started Sep 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05330338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330338.